FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC


Posted in: Medical Condition News | Pharmaceutical News

Tags: Abdominal Pain, Anemia, Birth Control, Bleeding, Blood, Blood Pressure, Blood Sugar, Brain, Brain Metastases, Breastfeeding, Cancer, Carboplatin, Cell, Chemotherapy, Chest Pain, Cisplatin, Clinical Trial, Constipation, Contraception, Corticosteroid, Cough, Creatinine, Diabetes, Diarrhea, Doctor, Evolution, Eye, Fatigue, Fever, Gene, Genomic, Grapefruit, Health Care, Healthcare, Heart, High Blood Sugar, Hyperglycemia, Kinase, Laboratory, Lipase, Liver, Long QT Syndrome, Lung Cancer, Lungs, Lymphoma, Mutation, Nausea, Neutropenia, Non-Small Cell Lung Cancer, Oncology, Pain, Pancreatitis, Pemetrexed, Pharmacist, Phosphatase, Prostate, Prostate Cancer, Protein, Radiation Therapy, Skin, Small Cell Lung Cancer, Stomach, Vomiting, Weight Loss